|
DTL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.77298192688613E-12 |
| Normal-vs-Stage2 |
1.478130E-02 |
| Normal-vs-Stage3 |
2.02299999996214E-06 |
| Normal-vs-Stage4 |
2.415600E-02 |
| Stage1-vs-Stage2 |
4.825000E-01 |
| Stage1-vs-Stage3 |
3.629400E-04 |
| Stage1-vs-Stage4 |
8.482000E-02 |
| Stage2-vs-Stage3 |
1.429760E-02 |
| Stage2-vs-Stage4 |
1.504790E-01 |
| Stage3-vs-Stage4 |
9.565400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.32005517627931E-13 |
| Normal-vs-AfricanAmerican |
1.71319999997532E-06 |
| Normal-vs-Asian |
6.465500E-02 |
| Caucasian-vs-AfricanAmerican |
5.511000E-01 |
| Caucasian-vs-Asian |
7.770000E-01 |
| AfricanAmerican-vs-Asian |
5.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63447033685316E-12 |
| Normal-vs-Female |
2.48210000330928E-08 |
| Male-vs-Female |
2.940700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.163560E-04 |
| Normal-vs-Extreme_Weight |
1.34199995560635E-09 |
| Normal-vs-Obese |
1.76413999999347E-05 |
| Normal-vs-Extreme_Obese |
1.648200E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.977800E-02 |
| Normal_Weight-vs-Obese |
9.100000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.960500E-03 |
| Extreme_Weight-vs-Obese |
1.896360E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.136300E-02 |
| Obese-vs-Extreme_Obese |
8.964600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.371960E-02 |
| Normal-vs-Age(41-60Yrs) |
6.04583050289875E-12 |
| Normal-vs-Age(61-80Yrs) |
9.9645003359683E-10 |
| Normal-vs-Age(81-100Yrs) |
3.215300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.016760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.068100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.992400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.798200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.329500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.522200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.19680043653148E-10 |
| Normal-VS-Type2 PRCC |
3.09230000494765E-08 |
| Normal-VS-KIRP CIMP |
3.396600E-03 |
| Normal-VS-Unclassified PRCC |
1.8380899999948E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.202400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.159100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.593600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.661790E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.288620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.844800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08170000000063E-05 |
| Normal-vs-N1 |
1.996200E-04 |
| Normal-vs-N2 |
9.542100E-02 |
| N0-vs-N1 |
4.782100E-03 |
| N0-vs-N2 |
5.898100E-02 |
| N1-vs-N2 |
6.159600E-01 |
|
|
